Novel biomarkers for progression of chronic kidney disease.
Liu
Bi-Cheng
BC
Institute of Nephrology, Zhong Da Hospital, Southeast University, Nanjing, Jiangsu 210009, China. liubc64@yahoo.com.cn
Lü
Lin-Li
LL
D000209:Acute-Phase Proteins / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism* / Q000652:urine; D016207:Cytokines / Q000378:metabolism; D050556:Fatty Acid-Binding Proteins / Q000378:metabolism; D000072596:Hepatitis A Virus Cellular Receptor 1; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism* / Q000652:urine; D000071068:Lipocalin-2; D054834:Lipocalins / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000378:metabolism; D040901:Proteomics; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D011991:Receptors, Virus / Q000378:metabolism
D000209:Acute-Phase Proteins; D015415:Biomarkers; D016207:Cytokines; D050556:Fatty Acid-Binding Proteins; C491143:HAVCR1 protein, human; D000072596:Hepatitis A Virus Cellular Receptor 1; C489506:LCN2 protein, human; D000071068:Lipocalin-2; D054834:Lipocalins; D008562:Membrane Glycoproteins; D011518:Proto-Oncogene Proteins; D011991:Receptors, Virus